ES2100165T3 - Produccion de superoxido dismutasa modificada. - Google Patents

Produccion de superoxido dismutasa modificada.

Info

Publication number
ES2100165T3
ES2100165T3 ES90312027T ES90312027T ES2100165T3 ES 2100165 T3 ES2100165 T3 ES 2100165T3 ES 90312027 T ES90312027 T ES 90312027T ES 90312027 T ES90312027 T ES 90312027T ES 2100165 T3 ES2100165 T3 ES 2100165T3
Authority
ES
Spain
Prior art keywords
modified
production
concentration
produced
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90312027T
Other languages
English (en)
Inventor
Yoshiyuki Nakano
Hajime Hiratani
Kazuo Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JCR Pharmaceuticals Co Ltd
Original Assignee
JCR Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JCR Pharmaceuticals Co Ltd filed Critical JCR Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2100165T3 publication Critical patent/ES2100165T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN DERIVADO DE DIIMIDAZOL DE CARBONILO POLIMERICO QUE TIENE LA FORMULA: EN DONDE R ES EL RESIDUO DE UN POLIMERO DISOLUBLE EN AGUA DE PESO MOLECULAR DE 2.000 A 10.000, POR EJEMPLO, POLIETILENGLICOL MONOMETOXI, PRODUCIDO AL HACER REACCIONAR EL POLIMERO CON CONCENTRACION DE 0.15 A 0.35 M CON UN CARBONILDIIMIDAZOL CON UNA CONCENTRACION DE 1:1 A 1:3. SE PRODUCE UNA DISMUTASA SUPEROXIDA MODIFICADA QUE TIENE LA FORMULA: AL HACER REACCIONAR DICHO DERIVADO CON DISMUTASA SUPEROXIDA ANTE LA PRESENCIA DE UNA CONCENTRACION DE 0.1 M A 0.5 M DE UN TAMPON ALCALINO QUE TIENE UN PH DE 9 A 11 A UNA TEMPERATURA DE 30 A 70 C. H//
ES90312027T 1989-11-02 1990-11-02 Produccion de superoxido dismutasa modificada. Expired - Lifetime ES2100165T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1286798A JP2978187B2 (ja) 1989-11-02 1989-11-02 修飾スーパーオキサイドディスムターゼの製造法

Publications (1)

Publication Number Publication Date
ES2100165T3 true ES2100165T3 (es) 1997-06-16

Family

ID=17709182

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90312027T Expired - Lifetime ES2100165T3 (es) 1989-11-02 1990-11-02 Produccion de superoxido dismutasa modificada.

Country Status (6)

Country Link
US (1) US5403731A (es)
EP (1) EP0426488B1 (es)
JP (1) JP2978187B2 (es)
CA (1) CA2029216A1 (es)
DE (1) DE69030553T2 (es)
ES (1) ES2100165T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04248984A (ja) * 1991-02-05 1992-09-04 Kuraray Co Ltd スーパーオキシドジスムターゼ誘導体およびその製造方法
JP3125428B2 (ja) * 1991-03-28 2001-01-15 和光純薬工業株式会社 修飾酵素
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5650234A (en) * 1994-09-09 1997-07-22 Surface Engineering Technologies, Division Of Innerdyne, Inc. Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
DE69628731T3 (de) * 1995-11-01 2012-09-20 Bracco Suisse S.A. Gezielte magnetisch markierte molekularmarkersysteme als nmr-bilderzeugungsmittel
US6190658B1 (en) 1998-05-08 2001-02-20 Webb-Waring Institute For Biomedical Research Genetically modified manganese superoxide dismutase for treating oxidative damage
WO2002100293A2 (en) * 2001-06-13 2002-12-19 Webb-Waring Institute For Biomedical Research A diagnostic and prognostic method for evaluating ocular inflammation and oxidative stress and the treatment of the same
US7192560B2 (en) 2001-12-20 2007-03-20 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using anion exchange
US7347976B2 (en) 2001-12-20 2008-03-25 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix
US7981600B2 (en) 2003-04-17 2011-07-19 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using an anion exchange material that includes a polyoxyalkylene
US20050130177A1 (en) 2003-12-12 2005-06-16 3M Innovative Properties Company Variable valve apparatus and methods
US7727710B2 (en) 2003-12-24 2010-06-01 3M Innovative Properties Company Materials, methods, and kits for reducing nonspecific binding of molecules to a surface
US7939249B2 (en) 2003-12-24 2011-05-10 3M Innovative Properties Company Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
DE102006040724A1 (de) * 2006-08-31 2008-03-06 Siemens Ag Verfahren und Vorrichtung zum Herstellen eines elektronischen Moduls und elektronisches Modul
CN109112119B (zh) * 2018-08-28 2022-04-26 佛山科学技术学院 经化学修饰的鸭血sod制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563349A (en) * 1980-07-30 1986-01-07 Takeda Chemical Industries, Ltd. Superoxide dismutase, its immobilized form, and their production and use
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ
JPS6279778A (ja) * 1985-10-04 1987-04-13 Suntory Ltd 新規ス−パ−オキシドデイスムタ−ゼ及びその製造方法
US5006333A (en) * 1987-08-03 1991-04-09 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols

Also Published As

Publication number Publication date
US5403731A (en) 1995-04-04
JPH03147784A (ja) 1991-06-24
EP0426488A1 (en) 1991-05-08
DE69030553D1 (de) 1997-05-28
CA2029216A1 (en) 1991-05-03
DE69030553T2 (de) 1998-01-22
EP0426488B1 (en) 1997-04-23
JP2978187B2 (ja) 1999-11-15

Similar Documents

Publication Publication Date Title
ATE80129T1 (de) Verfahren zur herstellung von synthetischen calciumsilicaten und ihre verwendungen.
AR246275A1 (es) Composiciones de catalizador, procedimiento para la preparacion de polimeros de monoxido de carbono, y eteno y nuevo compuesto.
ES2100878T3 (es) Material organico estabilizado.
ES2093672T3 (es) Composicion blanqueante liquida acuosa.
KR900004765A (ko) 나일론 변성 고무 조성물
ES2157680T3 (es) Sintesis de disulfuros y polisulfuros organicos.
NO880322D0 (no) Raaolje- og brenselsoljesammensetninger.
AR030682A1 (es) COMPOSICIONES QUE CONTIENEN POLICARBONATO , PROCEDIMIENTO PARA SU PRODUCCIoN, EMPLEO DE DICHAS COMPOSICIONES PARA LA FABRICACIoN DE CUERPOS MOLDEADOS O DE PIEZAS MOLDEADAS DE CUALQUIER TIPO, CUERPOS MOLDEADOS O PIEZAS MOLDEADAS OBTENIBLES A PARTIR DE DICHAS COMPOSICIONES.
PE95099A1 (es) Metodo para producir borato calcico
DE69020645D1 (de) Antitumor- und Antibiotikum-Substanz, ihre Herstellung und Verwendungen.
AR247892A1 (es) Polimeros a base de poli(carbonato de vinileno) y/o poli(hidroximetileno), procedimiento para su preparacion y empleo en un articulo, una tira de ensayo y una substancia biologicamente activa
ES2156302T3 (es) Procedimiento para la preparacion de disulfuros y de polisulfuros organicos.
ES2174237T3 (es) Sal sodica del acido (poli-(2-5-dihidroxi-fenilen))-4-tiosulfurico de estructura lineal como regulador del metabolismo celular y su procedimiento de fabricacion.
ATE397214T1 (de) Herstellung lumineszierender 10,10'- substituierter 9,9'- bis-acridin-derivate und signallösungen
EP0280271A3 (en) Arylene sulfide polymers
ES2085066T3 (es) Procedimiento para la obtencion catalitica de productos de condensacion de formaldehido.
KR940014241A (ko) 광재 저감재, 그것을 사용하여 이루어진 원심력 성형체 및 그의 제조방법
ES348228A1 (es) Procedimiento para la preparacion de anhidridos de acido bis-carboxilico.
MX9401260A (es) COMPUESTO DE BIBENZOATO DE BIS-ß-HIDROXIETILO.
BR9906894A (pt) Processo para preparar n-fenilquinona-imina.
FR2666336B1 (fr) Procede de fabrication du thiophene.
ES2060298T3 (es) La produccion de metilaminas.
ATE39348T1 (de) Riechstoffe und ihre herstellung.
FI915953A0 (fi) Parannettu isepamisiinin valmistusmenetelmä
FR2642753B1 (fr) Synthese d'alcanedithiols vicinaux

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 426488

Country of ref document: ES